Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry ; volume:117 ; number:12 ; year:2017 ; pages:2376-2388
Thrombosis and haemostasis ; 117, Heft 12 (2017), 2376-2388

Contributor
Mazurek, Michał
Huisman, Menno V.
Rothman, Kenneth J.
Paquette, Miney
Teutsch, Christine
Diener, Hans-Christoph
Dubner, Sergio J.
Halperin, Jonathan L.
Ma, Chang Sheng
Zint, Kristina
Elsaesser, Amelie
Lu, Shihai
Lip, Gregory Y. H.

DOI
10.1160/TH17-08-0555
URN
urn:nbn:de:101:1-2018102807434428224727
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:59 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Mazurek, Michał
  • Huisman, Menno V.
  • Rothman, Kenneth J.
  • Paquette, Miney
  • Teutsch, Christine
  • Diener, Hans-Christoph
  • Dubner, Sergio J.
  • Halperin, Jonathan L.
  • Ma, Chang Sheng
  • Zint, Kristina
  • Elsaesser, Amelie
  • Lu, Shihai
  • Lip, Gregory Y. H.

Other Objects (12)

Managing high-risk atrial fibrillation patients with multiple comorbidities

Managing high-risk atrial fibrillation patients with multiple comorbidities

Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?

Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?

Management of Device Detected Subclinical Atrial Fibrillation

Management of Device Detected Subclinical Atrial Fibrillation

Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry : Trends in antithrombotic therapy use in China

Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry : Trends in antithrombotic therapy use in China

Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation

Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation

Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey

Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey

The effect of hypertension on cerebrovascular carbon dioxide reactivity in atrial fibrillation patients

The effect of hypertension on cerebrovascular carbon dioxide reactivity in atrial fibrillation patients

The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis—a nationwide cohort study

The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis—a nationwide cohort study

Time in target range of systolic blood pressure and clinical outcomes in atrial fibrillation patients: results of the COOL-AF registry

Time in target range of systolic blood pressure and clinical outcomes in atrial fibrillation patients: results of the COOL-AF registry

Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry

Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry

Introducing Our New Offspring Journal … TH Open

Introducing Our New Offspring Journal … TH Open

Editors' Choice in the 60th Anniversary Year of Thrombosis and Haemostasis: Past, Present and Future

Editors' Choice in the 60th Anniversary Year of Thrombosis and Haemostasis: Past, Present and Future

Related objects